The weekly litigation news digest is live. Subscribe now

IP Verse

Astrazeneca Pharmaceuticals competitive analysis

Loading summary...

Latest patents of Astrazeneca Pharmaceuticals opposed by its competitors

Explore Astrazeneca Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Dec 11, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP4175619
Apr 10, 2024Compositions, Methods And Systems For Aerosol Drug Delivery2
EP4175620
Apr 10, 2024Compositions, Methods And Systems For Aerosol Drug Delivery1
EP4197528
Apr 3, 2024Compositions, Methods And Systems For Aerosol Drug Delivery1
EP2341905
Sep 13, 2023Sustained Release Formulations Using Non-Aqueous Carriers1
EP3329018
Mar 31, 2021Methods For Treating Hepcidin-Mediated Disorders1
EP2347762
May 8, 2019Exendin For Treating Diabetes And Reducing Body Weight2

Latest PTAB cases involving Astrazeneca Pharmaceuticals

Discover the latest PTAB cases involving Astrazeneca Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Astrazeneca Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Dec 11, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ASTRAZENECA PHARMACEUTICALS LP - 7 - -
BRAND MURRAY FULLER24 - - -
ELKINGTON AND FIFE92 - - -
INSTONE7 - - -